Investigation of the mechanisms of hepatic insul in sensitization by retinoi cacid.
Project/Area Number |
23790819
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Gastroenterology
|
Research Institution | Kyoto Pharmaceutical University |
Principal Investigator |
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | レチノイン酸 / タミバロテン / インスリン抵抗性 / レプチン / STAT3 / 肝臓 / NAFLD / NASH / アンチセンスRNA |
Research Abstract |
Based on our original finding, the leptin-dependent hepatic insulinsensitization by retinoid, I investigated its precise mechanisms. It was demonstrated thatretinoid activates hepatic leptin signaling by directly inducing leptin receptor expressionvia retinoid receptor. A synthetic rtinoid, tamibarotene, also showed the same effect,suggesting its potential as a novel insulin-resistance treatment. Moreover, AntiX wasidentified as a target gene of hepatic leptin signaling, and the expression level of AntiX inthe liver was significantly correlated with the pathological status of insulin resistance.
|
Report
(3 results)
Research Products
(17 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Retinoids ameliorate insulin resistance in a leptin-dependent manner.2011
Author(s)
Hiroyuki Tsuchiya, Yu Ebata, Chihiro Kojima, Yoshito Ikeda, Rikutaro Katsuma, Tomohiko Sakabe, Susumu Hama, Tatsuaki Tsuruyama, Koichi Shudo, Kentaro Kogure, and Goshi Shiota
Organizer
The 3rd EMBO meeting
Place of Presentation
VIENNA
Related Report